Up a level |
Marsden, John, Kelleher, Mike, Hoare, Zoe, Hughes, Dyfrig ORCID: 0000-0001-8247-7459, Bisla, Jatinder, Cape, Angela, Cowden, Fiona, Day, Edward, Dewhurst, Jonathan, Evans, Rachel et al (show 14 more authors)
(2022)
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone.
TRIALS, 23 (1).
697-.
Marsden, John ORCID: 0000-0002-1307-2498, Kelleher, Mike, Gilvarry, Eilish, Mitcheson, Luke, Bisla, Jatinder, Cape, Angela, Cowden, Fiona, Day, Edward ORCID: 0000-0002-7106-7013, Dewhurst, Jonathan, Evans, Rachel et al (show 13 more authors)
(2023)
Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial.
EClinicalMedicine, 66.
102311-.